Literature DB >> 18922126

Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.

Yaacov Richard Lawrence1, Maria Werner-Wasik, Adam P Dicker.   

Abstract

'Conformal radiation therapy' is the standard of care in radiation oncology, referring to the process of shaping the radiation beam to precisely match a tumor's physical dimensions. We describe 'biologically conformal radiotherapy', in which the radiation oncologist matches the prescribed treatment to a tumor's biological characteristics and the host's predicted tolerance of radiation. This paradigm emphasizes that not all tumors are equally sensitive to radiation; conversely, some patients are especially susceptible to radiation's side effects. Patients bearing radioresistant tumors or those prone to toxicity may be best treated with the incorporation of targeted radiation modulators or, in extreme cases, by a different modality. The biological characteristics of tumors can be assessed by a wide range of techniques: functional imaging (positron emission tomography and advanced magnetic resonance imaging), single gene/protein molecular techniques and 'omic' technologies. This paper reviews the latest advances in the use of biomarkers and functional imaging in guiding patients to receive the most appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922126      PMCID: PMC3926950          DOI: 10.2217/14796694.4.5.689

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  124 in total

1.  The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis.

Authors:  Jordi Giralt; Manuel de las Heras; Laura Cerezo; Aranzazu Eraso; Edurado Hermosilla; Dolores Velez; Juan Lujan; Eloi Espin; Jose Rosello; Joaquin Majó; Sergi Benavente; Manel Armengol; I de Torres
Journal:  Radiother Oncol       Date:  2005-02       Impact factor: 6.280

2.  Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

Authors:  B Michael Ghadimi; Marian Grade; Michael J Difilippantonio; Sudhir Varma; Richard Simon; Cristina Montagna; Laszlo Füzesi; Claus Langer; Heinz Becker; Torsten Liersch; Thomas Ried
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

3.  Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?

Authors:  Theodore Girinsky; Mithra Ghalibafian; Guillaume Bonniaud; Aziz Bayla; Nicolas Magne; Ivaldo Ferreira; Jean Lumbroso
Journal:  Radiother Oncol       Date:  2007-08-23       Impact factor: 6.280

4.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

Review 5.  Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.

Authors:  Thierry Berghmans; Michèle Dusart; Marianne Paesmans; Claude Hossein-Foucher; Irene Buvat; Catherine Castaigne; Arnaud Scherpereel; Céline Mascaux; Michel Moreau; Martine Roelandts; Stéphane Alard; Anne-Pascale Meert; Edward F Patz; Jean-Jacques Lafitte; Jean-Paul Sculier
Journal:  J Thorac Oncol       Date:  2008-01       Impact factor: 15.609

6.  Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.

Authors:  Caroline Rimkus; Jan Friederichs; Anne-Laure Boulesteix; Jörg Theisen; Jörg Mages; Karen Becker; Hjalmar Nekarda; Robert Rosenberg; Klaus-Peter Janssen; Jörg Rüdiger Siewert
Journal:  Clin Gastroenterol Hepatol       Date:  2008-01       Impact factor: 11.382

7.  HER2 and response to paclitaxel in node-positive breast cancer.

Authors:  Daniel F Hayes; Ann D Thor; Lynn G Dressler; Donald Weaver; Susan Edgerton; David Cowan; Gloria Broadwater; Lori J Goldstein; Silvana Martino; James N Ingle; I Craig Henderson; Larry Norton; Eric P Winer; Clifford A Hudis; Matthew J Ellis; Donald A Berry
Journal:  N Engl J Med       Date:  2007-10-11       Impact factor: 91.245

8.  Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.

Authors:  Julie K Schwarz; Barry A Siegel; Farrokh Dehdashti; Perry W Grigsby
Journal:  JAMA       Date:  2007-11-21       Impact factor: 56.272

9.  Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis.

Authors:  Khalid Puthawala; Nicos Hadjiangelis; Steven C Jacoby; Emmanuel Bayongan; Zhicheng Zhao; Zhiwei Yang; Mary Louise Devitt; Gerald S Horan; Paul H Weinreb; Matvey E Lukashev; Shelia M Violette; Kristen S Grant; Cristina Colarossi; Silvia C Formenti; John S Munger
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

10.  COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.

Authors:  Li-Yan Khor; Kyounghwa Bae; Alan Pollack; M Elizabeth H Hammond; David J Grignon; Varagur M Venkatesan; Seth A Rosenthal; Mark A Ritter; Howard M Sandler; Gerald E Hanks; William U Shipley; Adam P Dicker
Journal:  Lancet Oncol       Date:  2007-09-18       Impact factor: 41.316

View more
  4 in total

1.  Molecular biology: the key to personalised treatment in radiation oncology?

Authors:  D G Hirst; T Robson
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

Review 2.  Imaging radiation-induced normal tissue injury.

Authors:  Mike E Robbins; Judy K Brunso-Bechtold; Ann M Peiffer; Christina I Tsien; Janet E Bailey; Lawrence B Marks
Journal:  Radiat Res       Date:  2012-02-21       Impact factor: 2.841

3.  Dose-dependent uptake of 3'-deoxy-3'-[(18) F]fluorothymidine by the bowel after total-body irradiation.

Authors:  Markus Hartenbach; Andreas Delker; Sabrina Hartenbach; Juli Schlichtiger; Sabrina Niedermoser; Carmen Wängler; Björn Wängler; Guido Böning; Franz Josef Gildehaus; Klement Neumaier; Kirsten Lauber; Klaus Kraft; Claus Belka; Marcus Hacker; Viktor Meineke; Peter Bartenstein
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

4.  Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy.

Authors:  Yongbin Wang; Guifang Gan; Bocheng Wang; Jinliang Wu; Yuan Cao; Dan Zhu; Yan Xu; Xiaona Wang; Hongxiu Han; Xiaoling Li; Ming Ye; Jiangmin Zhao; Jun Mi
Journal:  EBioMedicine       Date:  2017-02-22       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.